期刊文献+

益气活血法治疗急性心肌梗塞的疗效观察 被引量:4

Observations on effect of benefiting qi for activating blood circulation therapy on AMI
原文传递
导出
摘要 目的 探讨益气活血中药对急性心肌梗塞的临床疗效.方法 临床随机分为两组各60例,对照组静脉滴注低分子右旋糖酐、硝酸甘油和肝素.一般用量硝酸甘油5~10 mg,肝素5000 U加于5%葡萄糖液250~500 ml中静滴.硝酸甘油用量开始时15μg/min,以后每3~5 min增加5~10μg/min,持续点滴,至症状得到控制.治疗组在对照组治疗基础上,加服益气活血中药治疗,两组均治疗2周为1个疗程,疗程结束后观察疗效.结果 治疗组总有效率为95.00%,对照组为81.67%,两组总有效率比较,差异有统计学意义(P=0.0341<0.05).随访3个月,治疗组发生缺血事件低于对照组(P=0.0284,P<0.05).结论 益气活血法结合西药治疗急性心肌梗塞优于单纯西医治疗,益气活血的中药有助于防治缺血事件的发生,改善患者预后. Objective To approach the effect of benefiting qi and activating blood circulation therapy on AMI.Methods A total of 120 patients with AMI were recruited into a control group and a treatment group randomly. 60 cases in control group were treated with dextran, nitroglycerin and heparin. While 60 cases in the treatment group were treated with traditional Chinese medicines with the functions of benefiting qi and activating blood circulation on the basis of the control group. Therapeutic effects were observed after two weeks' treatment. Results The effective rat was 95.00% and 81.67% in the treatment group and the control group respectively, showing significant difference(P=0.0341 <0.05). In the 3 months follow-up, ischemia happened in the treatment group was significantly lower than the control group (P=0.0284, P<0.05).Conclusion Combined treatment of TCM and western medicine is better than treatment of western medicine only. Benefiting qi and activating blood circulation therapy is effective on AMI and improves the prognosis.
出处 《国际中医中药杂志》 2010年第4期303-304,共2页 International Journal of Traditional Chinese Medicine
关键词 急性心肌梗塞 益气活血法 AMI Benefiting qi and activating blood circulation therapy
  • 相关文献

参考文献2

二级参考文献14

  • 1Sacks FM. Lipid-lowering therapy in acute coronary syndromes[J].JAMA, 2001, 285:1758-1760.
  • 2Mueck AO, Seeger H, Risch M, et al. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules [J]. Exp Clin Endocrinol Diabetes, 2001,109:181-183.
  • 3Ess SM, Szucs TD. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy[J]. Ital Heart J, 2001, 2 : 181-188.
  • 4Capurse A. Le Promesse delle statine. The promise of statins[J]. Ital Heart J, 2001, 2:224-229.
  • 5Chirkov YY, Holmes AS, Willoughby SR, et al.Stable angina and acute coronary syndromes are associate with nitric oxide resistance in platelets [J]. J Am Coll Cardiol, 2001, 37:1851-1857.
  • 6Osamah H, Mira R, Sorina S,et al. Reduced platelet aggregation after fluvastatin therapy isassociated wish altered platelet lipid composition and drug binding to the platelets[J]. Br J Clin Pharmacol. 1997,44 : 77-83.
  • 7Puccetti L, Bruni F, Bova G, et al. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects[J]. Nutr Metab Cardiovasc Dis. 2001,11: 378-387.
  • 8Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V and X Ⅱ and by enhanccing factor Va inactivation [J]. Circulation, 2001, 103:2248-2253.
  • 9Wiesbauer F, Kaun C, Zorn G, et al. HMG-CoA reductase inhibitors affect the fibrinolytic system of human vacular ells in vitro: a comparative study using different statins[-J]. Br J Phrmacol. 2002, 135:284-292.
  • 10Giroma J, La Ville AE ,Sola R,et al. Simvastatin decreases aldehyde production derived form lipoprotein oxidation[J]. Am J Cardiol, 1999, 83: 846-851.

共引文献1

同被引文献19

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部